|
|
Volume 1 Number 1 2012 |
|
| Original Article |
| Stem Cell Therapy - Liver Disease and Regenerative Medicine |
|
| Rosy Vennila |
|
|
[Abstract] |
[PDF]
|
|
| Angiogenesis: The formation of Blood Vessels |
|
| Suvro Chatterjee |
|
|
[Abstract] |
[PDF]
|
|
| Microarrays: Bidding Adieu? |
|
| V.L. Ram Prasad |
|
|
[Abstract] |
[PDF]
|
|
| Medical Biotechnology and the Challenge of Chronic disease |
|
| B.S. Ramakrishna |
|
|
[Abstract] |
[PDF]
|
|
| Molecular Pathogenesis of Immune System Disorders |
|
| Madhumathi |
|
|
[Abstract] |
[PDF]
|
|
| Application of Next Generation Sequencing in Fundamental and Clinical Sciences |
|
| Karthi Sivaraman |
|
|
[Abstract] |
[PDF]
|
|
| Study on CD40L mimetic molecules on Dendritic cells |
|
| S. Sivagami |
|
|
[Abstract] |
[PDF]
|
|
| Stem Cells: A Promising Candidate for cardiovascular Diseases |
|
| R.Sumathy |
|
|
[Abstract] |
[PDF]
|
|
| Applications of Tissue Microarray (TMA) platform for the Molecular characterization of Cancers |
|
| Siddhartha Roy |
|
|
[Abstract] |
[PDF]
|
|
| Stem cell transplantation and Cancer Treatment: Our experience from a Super-specialty Oncology Hospital |
|
| Siddhartha Roy |
|
|
[Abstract] |
[PDF]
|
|
| Interaction studies of active ingredients of Withania somnifera (Ashwagandha) with Beta-1 adrenergic receptor: A target for Cardiovascular Disease |
|
| Nitika Sharma |
|
|
[Abstract] |
[PDF]
|
|
| PknE, a Serine / Threonine kinase from Mycobacterium tuberculosis modulates apoptosis and arginase signalling in macrophages |
|
| Dinesh Kumar P |
|
|
[Abstract] |
[PDF]
|
|
| Effects of overexpression of signal recognition particle receptor (FtsY) in Mycobacteria |
|
| Malini Veerasamy |
|
|
[Abstract] |
[PDF]
|
|
| Development of Recombinant BCG Based Epitope Vaccine Candidate for Tuberculosis |
|
| Aparna Christy |
|
|
[Abstract] |
[PDF]
|
|
| Study of Chick Chorioallantoic membrane to test anti-angiogenesis Activity |
|
| D. Shanmugapriya |
|
|
[Abstract] |
[PDF]
|
|
| Effects of Oxidative stress in Patients with Rheumatoid Arthritis |
|
| D. Vijayakumar |
|
|
[Abstract] |
[PDF]
|
|
| Modulatory effect of PPAR-gamma agonist pioglitazone on preosteoclast cells of Type2 diabetic subjects |
|
| Thanigaivelan K |
|
|
[Abstract] |
[PDF]
|
|
| Association of Monocyte Chemoattractant Protein (MCP) 1 gene 2518 A/G Polymorphism with Type2 Diabetic Nephropathy in South Indian Population |
|
| Yaongamphi Vashum |
|
|
[Abstract] |
[PDF]
|
|
| Regulatory Role of PPAR-gamma Agonist Pioglitazone in Osteoclastogenesis of Type2 Diabetic Postmenopausal Women |
|
| Zenith Khashim |
|
|
[Abstract] |
[PDF]
|
|
| Association of Endothelial nitric oxide synthase gene Glu298Asp polymorphism in Type2 diabetic foot ulcer among south Indian population |
|
| Tholcopiyan.L1 |
|
|
[Abstract] |
[PDF]
|
|
| Study on finding the role of Peroxisome Proliferator – Activated Receptor -g (PPAR-gamma) agonist Pioglitazone in A549 Lung Adenocarcinoma Cell line |
|
| Purushoth E1 |
|
|
[Abstract] |
[PDF]
|
|
| In Silico Structure Based Designing of Potent Peptide Inhibitors for Renin and Angiotensin Converting Enzymes |
|
| Sampoornam B |
|
|
[Abstract] |
[PDF]
|
|
| Omega-3 Fatty acids from marine microbes |
|
| Abirami S* |
|
|
[Abstract] |
[PDF]
|
|
| Screening of Nattokinase Enzyme Producing Microorganisms |
|
| Rajani Gopal Gad* |
|
|
[Abstract] |
[PDF]
|
|
| Calculation of Secondary structure factors for the Medicinal Plant Cissus quardrangularis |
|
| K.Ramanadhan |
|
|
[Abstract] |
[PDF]
|
|
| Targeted drug delivery using niosome: The magic bullet |
|
| S. Henna Rohiya |
|
|
[Abstract] |
[PDF]
|
|
| Treatment of spinal cord injury using human bone marrow derived neural stem cell-like cells |
|
| Hemavathy Nagarajan |
|
|
[Abstract] |
[PDF]
|
|
| Treatment for alkaptonuria by gene therapy |
|
| B. Vinodhini |
|
|
[Abstract] |
[PDF]
|
|
| Shortcommunication |
| Biology of Angiogenesis |
|
| Suvro Chatterjee |
|
|
[Abstract] |
[PDF]
|
|
Author Information Pack
Editorial Board 
Submit article
Editor's selection process
Most popular articles
Archive
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us